PD-616
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-616, covering 2018-07-24 to 2018-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 1, Phase 2]